Genomenon's CKB is recognized globally for its exhaustive, evidence-based curation of somatic variants and their clinical ...

The test is currently available in private healthcare facilities but there are hopes it may be adopted by the NHS.

AI enhances traditional HTA by improving accuracy and efficiency. Artificial intelligence addresses key limitations of ...

Irish women and people who get periods are all too familiar with the stigma surrounding them in Ireland. We have come so far in recent years ...

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient ...

AbbVie's Phase 3 VERONA trial in HR-MDS showed no overall survival benefit for venetoclax-azacitidine; existing uses of ...

The high-end cellomics market size has grown robustly in recent times, scaling from $2.90 billion in 2024 to $3.15 billion in 2025, marking a compound annual growth rate CAGR of 8.6%. The surge in ...

The retina has always served as an invaluable, non-invasive portal to the vascular system, with retinal microvascular changes ...

The Middle East and Africa point-of-care diagnostics market is set for transformative growth, driven by rising demand for rapid and accurate diagnostic solutions. Valued at US$ 3.18 billion in 2025, ...